NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

CERS

Cerus Corp

Jul 08 • 04:00PM ET

1.46

Dollar change +0.01
Percentage change 0.69	%

Healthcare • Medical Devices • USA • NASD

Peers: QDEL BIO HCSG AEMD ARWR AXDX MMSI FATE INSP XERS

| Held by: ARKK ARKG VTI IWM VXF IWO SCHA VTWO FESM SMLF

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.10	Insider Own	6.58%	Shs Outstand	191.11M	Perf Week	3.55%
Market Cap	279.09M	Forward P/E	-	EPS next Y	-0.04	Insider Trans	-6.22%	Shs Float	178.59M	Perf Month	5.80%
Enterprise Value	298.37M	PEG	-	EPS next Q	-0.03	Inst Own	75.55%	Short Float	3.76%	Perf Quarter	17.74%
Income	-18.95M	P/S	1.51	EPS this Y	4.55%	Inst Trans	2.41%	Short Ratio	5.44	Perf Half Y	-7.01%
Sales	185.14M	P/B	5.03	EPS next Y	64.29%	ROA	-9.57%	Short Interest	6.72M	Perf YTD	-5.19%
Book/sh	0.29	P/C	3.45	EPS next 5Y	-	ROE	-36.14%	52W High	2.54 -42.52%	Perf Year	-15.12%
Cash/sh	0.42	P/FCF	41.59	EPS past 3/5Y	29.07% 25.97%	ROIC	-14.32%	52W Low	1.12 30.36%	Perf 3Y	-72.40%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	11.27% 13.96%	Gross Margin	56.00%	Volatility	6.26% 6.51%	Perf 5Y	-77.88%
Dividend TTM	-	EV/Sales	1.61	EPS Y/Y TTM	41.50%	Oper. Margin	-18.22%	ATR (14)	0.09	Perf 10Y	-72.03%
Dividend Ex-Date	-	Quick Ratio	1.63	Sales Y/Y TTM	13.06%	Profit Margin	-10.23%	RSI (14)	54.90	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	2.32	EPS Q/Q	22.56%	SMA20	3.80%	Beta	1.55	Target Price	4.67
Payout	-	Debt/Eq	1.79	Sales Q/Q	12.70%	SMA50	7.82%	Rel Volume	0.66	Prev Close	1.45
Employees	281	LT Debt/Eq	1.38	Earnings	May 01 AMC	SMA200	-7.80%	Avg Volume	1.23M	Price	1.46
IPO	Jan 31, 1997	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.00% -1.44%	Trades		Volume	820,945	Change	0.69%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-12-24	Initiated	Craig Hallum	Buy	$5
Jan-20-23	Downgrade	BTIG Research	Buy → Neutral
Jan-17-23	Downgrade	Stephens	Overweight → Equal-Weight	$3.75
Oct-08-20	Resumed	BTIG Research	Buy	$9
Jun-16-20	Resumed	Cantor Fitzgerald	Overweight	$9
Feb-26-20	Initiated	BTIG Research	Buy	$7
Nov-13-19	Upgrade	BTIG Research	Neutral → Buy	$7
Aug-28-19	Initiated	Stifel	Buy
Aug-23-19	Resumed	Stephens	Overweight
Jan-05-18	Resumed	Cantor Fitzgerald	Overweight
Dec-08-17	Resumed	BTIG Research	Neutral
Jul-07-16	Resumed	Cantor Fitzgerald	Buy	$9
Dec-17-15	Downgrade	Wedbush	Outperform → Neutral
May-02-14	Reiterated	MLV & Co	Buy	$8.50 → $6
Apr-24-13	Reiterated	Cantor Fitzgerald	Buy	$5.50 → $6
Mar-15-13	Reiterated	MLV & Co	Buy	$7.50 → $8.50
Apr-17-12	Initiated	Cantor Fitzgerald	Buy	$5.50
Feb-29-12	Upgrade	Robert W. Baird	Neutral → Outperform	$3 → $6
Nov-10-11	Reiterated	MLV & Co	Buy	$4 → $5
Jun-03-11	Initiated	Wedbush	Outperform	$4

Show Previous Ratings

Jul-02-25 08:30AM	Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update (Business Wire) +5.41%
Jun-13-25 04:01PM	Cerus Corporation Celebrates World Blood Donor Day 2025 (Business Wire) +6.82%
Jun-03-25 04:30PM	Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025 (Business Wire) +9.09%
May-29-25 08:30AM	Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan (Business Wire)
May-28-25 08:30AM	Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 Next-Generation INTERCEPT Illumination Device (Business Wire)
08:26PM	Loading…
May-01-25 08:26PM	Cerus Corporation (CERS) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:05PM	Cerus (CERS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:07PM	Cerus: Q1 Earnings Snapshot (Associated Press Finance)
04:00PM	Cerus Corporation Announces First Quarter 2025 Financial Results (Business Wire)
Apr-17-25 08:30AM	Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025 (Business Wire)
Mar-06-25 11:44AM	Cerus secures CE mark approval for LED-based illumination device (Medical Device Network)
Mar-05-25 01:00PM	Cerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200) (Business Wire)
Feb-21-25 02:14AM	Cerus Corp (CERS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Positive Cash Flow (GuruFocus.com) -5.17%
Feb-20-25 04:20PM	Cerus: Q4 Earnings Snapshot (Associated Press Finance)
04:00PM	Cerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial Results (Business Wire)
09:27AM	Loading…
09:27AM	What To Expect From Cerus Corp (CERS) Q4 2024 Earnings (GuruFocus.com)
Feb-19-25 04:00PM	Cerus Corporation to Participate in the TD Cowen 45th Annual Health Care Conference (Business Wire)
Feb-07-25 08:30AM	Cerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025 (Business Wire)
Jan-13-25 08:30AM	Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business Update (Business Wire) +5.70%
Nov-13-24 08:30AM	Cerus Corporation to Participate in Upcoming Investor Conferences (Business Wire)
Oct-31-24 02:11PM	Q3 2024 Cerus Corp Earnings Call (Thomson Reuters StreetEvents) -8.72%
05:01AM	Cerus Corp (CERS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Oct-30-24 05:10PM	Cerus (CERS) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:06PM	Cerus: Q3 Earnings Snapshot (Associated Press Finance)
04:00PM	Cerus Corporation Announces Third Quarter 2024 Financial Results (Business Wire)
Oct-29-24 09:16AM	Cerus Corp (CERS) Q3 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-18-24 08:30AM	Cerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024 (Business Wire)
08:30AM	Cerus Corporation Announces Workshop and Abstracts at the 2024 AABB Annual Meeting (Business Wire)
08:25AM	Cerus price target lowered to $3 from $6 at Stifel (TipRanks)
Oct-16-24 04:00PM	Cerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and Europe (Business Wire) -9.44%
03:49PM	Loading…
Oct-09-24 03:49PM	Cerus Corp (CERS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Positive EBITDA (GuruFocus.com) +8.72%
Sep-06-24 01:47AM	Insider Selling: CFO Kevin Green Sells 82,657 Shares of Cerus Corp (CERS) (GuruFocus.com)
Aug-01-24 05:10PM	Cerus (CERS) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -9.73% +14.95%
04:07PM	Cerus: Q2 Earnings Snapshot (Associated Press Finance)
04:00PM	Cerus Corporation Announces Second Quarter 2024 Financial Results and Increases Full-Year 2024 Product Revenue Guidance Range (Business Wire)
Jul-18-24 08:30AM	Cerus Corporation to Release Second Quarter 2024 Financial Results on August 1, 2024 (Business Wire) -6.36%
Jul-02-24 04:00PM	Cerus Corporation Announces Appointment of Dean Gregory to Board of Directors (Business Wire)
Jun-21-24 08:30AM	Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion (Business Wire)
Jun-14-24 08:30AM	Cerus Corporation Celebrates World Blood Donor Day 2024 (Business Wire)
May-22-24 08:30AM	Cerus Corporation to Participate in 21st Annual Craig-Hallum Institutional Investor Conference (Business Wire)
May-03-24 10:40AM	Cerus Corporation (NASDAQ:CERS) Q1 2024 Earnings Call Transcript (Insider Monkey) -7.95%
06:48AM	Q1 2024 Cerus Corp Earnings Call (Thomson Reuters StreetEvents)
03:58AM	Cerus Corp (CERS) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-02-24 08:59PM	CERS Stock Earnings: Cerus Meets EPS, Misses Revenue for Q1 2024 (InvestorPlace)
06:04PM	Cerus Corp (CERS) Q1 2024 Earnings: Revenue Surpasses Estimates, Net Loss Narrows (GuruFocus.com)
04:04PM	Cerus: Q1 Earnings Snapshot (Associated Press Finance)
04:00PM	Cerus Corporation Announces First Quarter 2024 Financial Results (Business Wire)
Apr-18-24 08:30AM	Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024 (Business Wire)
Mar-26-24 08:30AM	Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets Doubling Previous Shelf Life (Business Wire)
Mar-19-24 08:00AM	Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients (Business Wire) +9.68%
Mar-15-24 01:49AM	Insider Sell: President and CEO William Greenman Sells 125,926 Shares of Cerus Corp (CERS) (GuruFocus.com)
01:48AM	Insider Sell: COO Vivek Jayaraman Sells 53,041 Shares of Cerus Corp (CERS) (GuruFocus.com)
Mar-07-24 01:40PM	Cerus Corp (CERS) Posts Narrowed Q4 Net Loss and Achieves Adjusted EBITDA Breakeven (GuruFocus.com)
11:46AM	Cerus Corporation (NASDAQ:CERS) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-06-24 06:23AM	Q4 2023 Cerus Corp Earnings Call (Thomson Reuters StreetEvents) +21.61%
Mar-05-24 09:53PM	CERS Stock Earnings: Cerus Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace) -6.13%
04:26PM	Cerus: Q4 Earnings Snapshot (Associated Press Finance)
04:00PM	Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results (Business Wire)
Feb-23-24 11:56AM	12 Best Rising Penny Stocks To Buy (Insider Monkey)
Feb-20-24 08:30AM	Cerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024 (Business Wire)
Feb-01-24 08:30AM	Cerus Corporation to Participate in Upcoming Investor Conferences (Business Wire) +8.84%
Jan-15-24 09:30AM	3 Growth Stocks That Could Go Parabolic in 2024 (Motley Fool)
Jan-08-24 08:30AM	Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2023 Product Revenue and Provides Business Update (Business Wire) +5.61%
Nov-03-23 09:19AM	Cerus Corporation (NASDAQ:CERS) Q3 2023 Earnings Call Transcript (Insider Monkey) +8.81%
08:30AM	Cerus Corporation to Participate in Upcoming Investor Conferences (Business Wire)
Nov-02-23 06:43PM	Cerus Corp (CERS) Q3 2023 Earnings: Product Revenue Stable, Operating Expenses Decrease by 4% (GuruFocus.com) +15.22%
05:25PM	Cerus (CERS) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:20PM	Cerus: Q3 Earnings Snapshot (Associated Press Finance)
04:00PM	Cerus Corporation Announces Third Quarter 2023 Financial Results (Business Wire)
Oct-19-23 08:30AM	Cerus Corporation to Release Third Quarter 2023 Financial Results on November 2, 2023 (Business Wire)
Oct-10-23 08:30AM	Cerus Corporation Announces Workshop and Abstracts at the 2023 AABB Annual Meeting (Business Wire) +8.02%
Sep-27-23 08:30AM	Cerus Corporation Announces the Appointment of Alicia Goodman as New Chief Human Resources Officer (Business Wire)
Sep-12-23 08:30AM	Cerus Corporation to Participate in the 2023 Cantor Global Healthcare Conference (Business Wire)
Aug-02-23 05:15PM	Cerus (CERS) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -17.98%
04:11PM	Cerus: Q2 Earnings Snapshot (Associated Press Finance)
04:00PM	Cerus Corporation Announces Second Quarter 2023 Financial Results (Business Wire)
Jul-31-23 12:36PM	Cerus (NASDAQ:CERS) investors are sitting on a loss of 60% if they invested three years ago (Simply Wall St.)
Jul-19-23 08:30AM	Cerus Corporation to Release Second Quarter 2023 Financial Results on August 2, 2023 (Business Wire) +5.42%
Jul-03-23 05:13PM	12 Best NASDAQ Penny Stocks to Buy (Insider Monkey) -7.76%
Jun-15-23 08:30AM	Cerus Corporation Announces Symposium and Abstracts at the 33rd Regional ISBT Congress (Business Wire)
Jun-14-23 08:30AM	Cerus Corporation Celebrates World Blood Donor Day 2023 (Business Wire)
Jun-07-23 10:30AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Jun-05-23 08:30AM	Cerus Corporation Announces Follow-on Award of U.S. Department of Defense Funding for Development of Pathogen Reduced, Lyophilized Cryoprecipitate (Business Wire)
May-30-23 07:16AM	With 72% institutional ownership, Cerus Corporation (NASDAQ:CERS) is a favorite amongst the big guns (Simply Wall St.) +5.70%
May-04-23 05:15PM	Cerus (CERS) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:10PM	Cerus: Q1 Earnings Snapshot (AP Finance)
04:00PM	Cerus Corporation Announces First Quarter 2023 Financial Results (Business Wire)
May-02-23 12:25PM	7 Best Cathie Wood Stocks for Your May 2023 Buy List (InvestorPlace) -8.09%
Apr-20-23 08:30AM	Cerus Corporation to Release First Quarter 2023 Financial Results on May 4, 2023 (Business Wire) -5.84%
Apr-18-23 10:54AM	Cerus Corporation (NASDAQ:CERS) Might Not Be As Mispriced As It Looks (Simply Wall St.)
Mar-10-23 09:24AM	Too Cheap to Ignore: Cathie Wood Snaps Up These 2 Stocks Under $10 (TipRanks)
Mar-09-23 11:45AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Feb-28-23 04:00PM	Cerus Corporation Announces Record Fourth Quarter and Full-Year 2022 Financial Results (Business Wire) -7.34%
Feb-21-23 11:00AM	Cerus (NASDAQ:CERS) shareholders have endured a 43% loss from investing in the stock a year ago (Simply Wall St.) -8.00%
Feb-15-23 08:30AM	Cerus Corporation to Release Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023 (Business Wire)
Feb-10-23 08:30AM	Cerus Corporation to Participate in Upcoming Investor Conferences (Business Wire)
Jan-19-23 11:45AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Jan-09-23 08:30AM	Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2022 Product Revenue and Provides Business Update (Business Wire) -28.04%
Dec-21-22 05:50AM	Cerus Corporation's (NASDAQ:CERS) recent 9.2% pullback adds to one-year year losses, institutional owners may take drastic measures (Simply Wall St.) +7.83%
Nov-09-22 05:58AM	Cerus Third Quarter 2022 Earnings: US$0.048 loss per share (vs US$0.072 loss in 3Q 2021) (Simply Wall St.)

Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jensen Chrystal	Chief Legal Officer	Mar 14 '25	Sale	1.45	30,075	43,609	783,294	Mar 17 05:02 PM
Jensen Chrystal	Chief Legal Officer	Mar 13 '25	Sale	1.45	18,949	27,476	813,369	Mar 17 05:02 PM
Jayaraman Vivek K	Chief Operating Officer	Mar 14 '25	Sale	1.45	46,004	66,706	1,431,326	Mar 17 05:01 PM
Jayaraman Vivek K	Chief Operating Officer	Mar 13 '25	Sale	1.45	29,985	43,478	1,477,330	Mar 17 05:01 PM
Greenman William Mariner	President and CEO	Mar 14 '25	Sale	1.45	122,827	178,099	4,115,845	Mar 17 05:00 PM
Greenman William Mariner	President and CEO	Mar 13 '25	Sale	1.45	71,086	103,075	4,238,672	Mar 17 05:00 PM
Green Kevin Dennis	Chief Financial Officer	Mar 14 '25	Sale	1.45	36,740	53,273	875,867	Mar 17 04:56 PM
Green Kevin Dennis	Chief Financial Officer	Mar 13 '25	Sale	1.45	23,147	33,563	912,607	Mar 17 04:56 PM
Benjamin Richard J	Chief Medical Officer	Mar 14 '25	Sale	1.45	30,075	43,609	685,775	Mar 17 04:55 PM
Benjamin Richard J	Chief Medical Officer	Mar 13 '25	Sale	1.45	18,949	27,476	715,850	Mar 17 04:55 PM
Jensen Chrystal	Chief Legal Officer	Mar 07 '25	Sale	1.50	27,457	41,131	832,318	Mar 10 07:59 PM
Jayaraman Vivek K	Chief Operating Officer	Mar 07 '25	Sale	1.50	33,999	50,931	1,507,315	Mar 10 07:56 PM
Greenman William Mariner	President and CEO	Mar 07 '25	Sale	1.50	60,984	91,354	4,309,758	Mar 10 07:55 PM
Green Kevin Dennis	Chief Financial Officer	Mar 07 '25	Sale	1.50	31,148	46,660	935,754	Mar 10 07:54 PM
Benjamin Richard J	Chief Medical Officer	Mar 07 '25	Sale	1.50	26,139	39,156	734,799	Mar 10 07:53 PM
Jensen Chrystal	Chief Legal Officer	Mar 04 '25	Sale	1.58	66,292	104,885	405,198	Mar 05 08:31 PM
Jayaraman Vivek K	Chief Operating Officer	Mar 04 '25	Sale	1.55	10,780	16,693	905,828	Mar 05 08:30 PM
Greenman William Mariner	President and CEO	Mar 04 '25	Sale	1.55	23,023	35,651	3,230,000	Mar 05 08:29 PM
Green Kevin Dennis	Chief Financial Officer	Mar 03 '25	Sale	1.58	60,656	95,673	493,862	Mar 05 08:27 PM
Green Kevin Dennis	Chief Financial Officer	Mar 04 '25	Sale	1.55	8,386	12,986	554,518	Mar 05 08:27 PM
Benjamin Richard J	Chief Medical Officer	Mar 03 '25	Sale	1.58	51,254	80,828	400,665	Mar 05 08:23 PM
Benjamin Richard J	Chief Medical Officer	Mar 04 '25	Sale	1.55	6,292	9,743	394,373	Mar 05 08:23 PM
Jensen Chrystal	Officer	Mar 04 '25	Proposed Sale	1.50	60,000	90,000		Mar 04 04:55 PM
RICHARD J BENJAMIN	Officer	Mar 03 '25	Proposed Sale	1.58	51,254	80,822		Mar 03 05:22 PM
KEVIN D GREEN	Officer	Mar 03 '25	Proposed Sale	1.58	60,656	95,646		Mar 03 04:56 PM
Gregory Dean A.	Director	Dec 13 '24	Buy	1.70	1,725	2,932	61,725	Jan 02 05:46 PM
BJERKHOLT ERIC	Director	Dec 12 '24	Sale	1.78	20,000	35,700	162,133	Dec 16 08:37 PM
Jensen Chrystal	Chief Legal Officer	Dec 16 '24	Sale	1.71	16,667	28,501	457,578	Dec 16 08:34 PM
CHRYSTAL NIKOLE JENSEN	Officer	Dec 16 '24	Proposed Sale	1.72	16,667	28,626		Dec 16 04:17 PM
BJERKHOLT ERIC	Director	Dec 12 '24	Proposed Sale	1.78	20,000	35,700		Dec 12 04:41 PM
Green Kevin Dennis	Chief Financial Officer	Sep 04 '24	Sale	2.15	54,272	116,826	536,093	Sep 05 05:05 PM
Green Kevin Dennis	Chief Financial Officer	Sep 03 '24	Sale	2.18	28,385	61,919	590,365	Sep 05 05:05 PM
KEVIN D GREEN	Officer	Sep 04 '24	Proposed Sale	2.15	54,272	116,826		Sep 04 04:14 PM
KEVIN D GREEN	Officer	Sep 03 '24	Proposed Sale	2.18	28,385	61,919		Sep 03 04:28 PM
Jensen Chrystal	Chief Legal Officer	Aug 15 '24	Sale	2.06	16,667	34,417	474,245	Aug 19 04:35 PM
CHRYSTAL NIKOLE JENSEN	Officer	Aug 15 '24	Proposed Sale	2.07	16,667	34,427		Aug 15 04:41 PM
Benjamin Richard J	Chief Medical Officer	Aug 02 '24	Sale	2.50	21,605	54,012	438,007	Aug 07 04:07 PM
RICHARD J BENJAMIN	Officer	Aug 02 '24	Proposed Sale	2.50	21,605	54,012		Aug 02 04:09 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CERS

Cerus Corp

Upgrade your FINVIZ experience